drugset / Trial / NCT03283020
Opioid-Induced Swallowing Dysfunction - The Impact of Bolus Volume
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of the study is to evaluate the impact of different bolus volumes and viscosity on remifentanil-induced swallowing dysfunction in healthy volunteers.Hence, whether swallowing tasks can be done safer during sedation by altering bolus volumes and viscosities will be revealed. Furthermore, the study will clarify underlying mechanisms (central vs. peripheral effects) of remifentanil-induced swallowing dysfunction. If methylnaltrexone reverses the remifentanil-induced effects on swallowing, this would suggest a dominant peripherally mediated mechanism.
Timeline
- Start
- 2017-11-11
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylnaltrexone | Other / unclassified | 0.3 mg/kg | Intravenous |
| Comparator | Remifentanil | Small molecule | 3 ng/ml | Intravenous |